EMEA (Europe, Middle East and Africa) Non-Insulin Therapies for Diabetes Market Report 2017

November 2017 | 113 pages | ID: E56C6F4A63EEN
QYResearch

Abstracts

In this report, the EMEA Non-Insulin Therapies for Diabetes market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (), revenue (Million USD), market share and growth rate of Non-Insulin Therapies for Diabetes for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Non-Insulin Therapies for Diabetes market competition by top manufacturers/players, with Non-Insulin Therapies for Diabetes sales volume (), price (), revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Eli Lilly
• Sumitomo Dainippon Pharma
• Intarcia Therapeutics
• Servier
• Jiangsu Hansoh Pharmaceutical
• Novo Nordisk
• Emisphere
• Uni-Bio Science Group
• Takeda
• 3SBio
• Merck
• Dong-A Pharmaceutical
• Luye Pharma Group
• Eurofarma
• Geropharm
• Alkem Labs
• SatRx
• Pfizer
• Jiangsu Hengrui Medicine

On the basis of product, this report displays the sales volume (), revenue (Million USD), product price (), market share and growth rate of each type, primarily split into

• Alpha-glucosidase Inhibitors
• Amylin Agonists
• Biguanides
• Dipeptidyl Peptidase-4 (DPP4) Inhibitors
• Glinides / Meglitinides
• GLP-1 Analogs / GLP-1 Agonists
• Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
• Sulfonylureas
• Thiazolidinediones
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (), market share and growth rate of Non-Insulin Therapies for Diabetes for each application, including

• Hospital Pharmacy
• Retail Pharmacies
• Online Pharmacy
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Non-Insulin Therapies for Diabetes Market Report 2017

1 NON-INSULIN THERAPIES FOR DIABETES OVERVIEW

1.1 Product Overview and Scope of Non-Insulin Therapies for Diabetes
1.2 Classification of Non-Insulin Therapies for Diabetes
  1.2.1 EMEA Non-Insulin Therapies for Diabetes Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Non-Insulin Therapies for Diabetes Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Alpha-glucosidase Inhibitors
  1.2.4 Amylin Agonists
  1.2.5 Biguanides
  1.2.6 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
  1.2.7 Glinides / Meglitinides
  1.2.8 GLP-1 Analogs / GLP-1 Agonists
  1.2.9 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
  1.2.10 Sulfonylureas
  1.2.11 Thiazolidinediones
  1.2.12 Others
1.3 EMEA Non-Insulin Therapies for Diabetes Market by Application/End Users
  1.3.1 EMEA Non-Insulin Therapies for Diabetes Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacy
  1.3.5 Others
1.4 EMEA Non-Insulin Therapies for Diabetes Market by Region
  1.4.1 EMEA Non-Insulin Therapies for Diabetes Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Non-Insulin Therapies for Diabetes (2012-2022)
  1.5.1 EMEA Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2022)

2 EMEA NON-INSULIN THERAPIES FOR DIABETES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Non-Insulin Therapies for Diabetes Market Competition by Players/Manufacturers
  2.1.1 EMEA Non-Insulin Therapies for Diabetes Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Non-Insulin Therapies for Diabetes Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Non-Insulin Therapies for Diabetes Sale Price by Players (2012-2017)
2.2 EMEA Non-Insulin Therapies for Diabetes (Volume and Value) by Type/Product Category
  2.2.1 EMEA Non-Insulin Therapies for Diabetes Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Non-Insulin Therapies for Diabetes Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Non-Insulin Therapies for Diabetes Sale Price by Type (2012-2017)
2.3 EMEA Non-Insulin Therapies for Diabetes (Volume) by Application
2.4 EMEA Non-Insulin Therapies for Diabetes (Volume and Value) by Region
  2.4.1 EMEA Non-Insulin Therapies for Diabetes Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Non-Insulin Therapies for Diabetes Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Non-Insulin Therapies for Diabetes Sales Price by Region (2012-2017)

3 EUROPE NON-INSULIN THERAPIES FOR DIABETES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
  3.1.1 Europe Non-Insulin Therapies for Diabetes Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
3.2 Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Type
3.3 Europe Non-Insulin Therapies for Diabetes Sales and Market Share by Application
3.4 Europe Non-Insulin Therapies for Diabetes Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Non-Insulin Therapies for Diabetes Sales Volume by Countries (2012-2017)
  3.4.2 Europe Non-Insulin Therapies for Diabetes Revenue by Countries (2012-2017)
  3.4.3 Germany Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
  3.4.4 France Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
  3.4.5 UK Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
  3.4.6 Russia Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
  3.4.7 Italy Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NON-INSULIN THERAPIES FOR DIABETES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
  4.1.1 Middle East Non-Insulin Therapies for Diabetes Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
4.2 Middle East Non-Insulin Therapies for Diabetes Sales and Market Share by Type
4.3 Middle East Non-Insulin Therapies for Diabetes Sales and Market Share by Application
4.4 Middle East Non-Insulin Therapies for Diabetes Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Non-Insulin Therapies for Diabetes Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Non-Insulin Therapies for Diabetes Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
  4.4.4 Israel Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
  4.4.5 UAE Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
  4.4.6 Iran Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

5 AFRICA NON-INSULIN THERAPIES FOR DIABETES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Non-Insulin Therapies for Diabetes Sales and Value (2012-2017)
  5.1.1 Africa Non-Insulin Therapies for Diabetes Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
5.2 Africa Non-Insulin Therapies for Diabetes Sales and Market Share by Type
5.3 Africa Non-Insulin Therapies for Diabetes Sales and Market Share by Application
5.4 Africa Non-Insulin Therapies for Diabetes Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Non-Insulin Therapies for Diabetes Sales Volume by Countries (2012-2017)
  5.4.2 Africa Non-Insulin Therapies for Diabetes Revenue by Countries (2012-2017)
  5.4.3 South Africa Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Non-Insulin Therapies for Diabetes Sales and Growth Rate (2012-2017)

6 EMEA NON-INSULIN THERAPIES FOR DIABETES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Eli Lilly
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eli Lilly Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sumitomo Dainippon Pharma
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Intarcia Therapeutics
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Servier
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Servier Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Jiangsu Hansoh Pharmaceutical
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novo Nordisk Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Emisphere
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Emisphere Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Uni-Bio Science Group
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Takeda
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Takeda Non-Insulin Therapies for Diabetes Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 3SBio
6.12 Merck
6.13 Dong-A Pharmaceutical
6.14 Luye Pharma Group
6.15 Eurofarma
6.16 Geropharm
6.17 Alkem Labs
6.18 SatRx
6.19 Pfizer
6.20 Jiangsu Hengrui Medicine

7 NON-INSULIN THERAPIES FOR DIABETES MANUFACTURING COST ANALYSIS

7.1 Non-Insulin Therapies for Diabetes Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Non-Insulin Therapies for Diabetes Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NON-INSULIN THERAPIES FOR DIABETES MARKET FORECAST (2017-2022)

11.1 EMEA Non-Insulin Therapies for Diabetes Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Non-Insulin Therapies for Diabetes Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Non-Insulin Therapies for Diabetes Price and Trend Forecast (2017-2022)
11.2 EMEA Non-Insulin Therapies for Diabetes Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Non-Insulin Therapies for Diabetes Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Non-Insulin Therapies for Diabetes Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Non-Insulin Therapies for Diabetes Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Non-Insulin Therapies for Diabetes Sales Forecast by Type (2017-2022)
11.7 EMEA Non-Insulin Therapies for Diabetes Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Non-Insulin Therapies for Diabetes
Figure EMEA Non-Insulin Therapies for Diabetes Sales Volume () by Type (2012-2022)
Figure EMEA Non-Insulin Therapies for Diabetes Sales Volume Market Share by Type (Product Category) in 2016
Figure Alpha-glucosidase Inhibitors Product Picture
Figure Amylin Agonists Product Picture
Figure Biguanides Product Picture
Figure Dipeptidyl Peptidase-4 (DPP4) Inhibitors Product Picture
Figure Glinides / Meglitinides Product Picture
Figure GLP-1 Analogs / GLP-1 Agonists Product Picture
Figure Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Product Picture
Figure Sulfonylureas Product Picture
Figure Thiazolidinediones Product Picture
Figure Others Product Picture
Figure EMEA Non-Insulin Therapies for Diabetes Sales Volume () by Application (2012-2022)
Figure EMEA Sales Market Share of Non-Insulin Therapies for Diabetes by Application in 2016
Figure Hospital Pharmacy Examples
Figure Retail Pharmacies Examples
Figure Online Pharmacy Examples
Figure Others Examples
Figure EMEA Non-Insulin Therapies for Diabetes Market Size (Million USD) by Region (2012-2022)
Figure Europe Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Non-Insulin Therapies for Diabetes Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Non-Insulin Therapies for Diabetes Revenue (Million USD) Status and Forecast by Countries
Figure Africa Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Non-Insulin Therapies for Diabetes Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Non-Insulin Therapies for Diabetes Sales Volume and Growth Rate (2012-2022)
Figure EMEA Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Non-Insulin Therapies for Diabetes Market Major Players Product Sales Volume () (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Sales Volume () of Major Players (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Sales Share by Players (2012-2017)
Figure 2016 Non-Insulin Therapies for Diabetes Sales Share by Players
Figure 2017 Non-Insulin Therapies for Diabetes Sales Share by Players
Figure EMEA Non-Insulin Therapies for Diabetes Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Revenue (Million USD) by Players (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Revenue Share by Players (2012-2017)
Table 2016 EMEA Non-Insulin Therapies for Diabetes Revenue Share by Players
Table 2017 EMEA Non-Insulin Therapies for Diabetes Revenue Share by Players
Table EMEA Non-Insulin Therapies for Diabetes Sale Price () by Players (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Sales () and Market Share by Type (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Sales Share by Type (2012-2017)
Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Type (2012-2017)
Figure EMEA Non-Insulin Therapies for Diabetes Sales Market Share by Type (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non-Insulin Therapies for Diabetes by Type in 2016
Table EMEA Non-Insulin Therapies for Diabetes Sale Price () by Type (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Sales () and Market Share by Application (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Sales Share by Application (2012-2017)
Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Application (2012-2017)
Figure EMEA Non-Insulin Therapies for Diabetes Sales Market Share by Application in 2016
Table EMEA Non-Insulin Therapies for Diabetes Sales () and Market Share by Region (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Sales Share by Region (2012-2017)
Figure Sales Market Share of Non-Insulin Therapies for Diabetes by Region (2012-2017)
Figure EMEA Non-Insulin Therapies for Diabetes Sales Market Share in 2016
Table EMEA Non-Insulin Therapies for Diabetes Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Non-Insulin Therapies for Diabetes Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Non-Insulin Therapies for Diabetes by Region (2012-2017)
Figure EMEA Non-Insulin Therapies for Diabetes Revenue Market Share Regions in 2016
Table EMEA Non-Insulin Therapies for Diabetes Sales Price () by Region (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Revenue and Growth Rate (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Sales () by Type (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Market Share by Type (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Market Share by Type in 2016
Table Europe Non-Insulin Therapies for Diabetes Sales () by Application (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Market Share by Application (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Market Share by Application in 2016
Table Europe Non-Insulin Therapies for Diabetes Sales () by Countries (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Sales Market Share by Countries (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Sales Market Share by Countries (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Sales Market Share by Countries in 2016
Table Europe Non-Insulin Therapies for Diabetes Revenue (Million USD) by Countries (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Revenue Market Share by Countries (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Revenue Market Share by Countries (2012-2017)
Figure Europe Non-Insulin Therapies for Diabetes Revenue Market Share by Countries in 2016
Figure Germany Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure France Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure UK Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Russia Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Italy Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Benelux Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Middle East Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Middle East Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Non-Insulin Therapies for Diabetes Sales () by Type (2012-2017)
Table Middle East Non-Insulin Therapies for Diabetes Market Share by Type (2012-2017)
Figure Middle East Non-Insulin Therapies for Diabetes Market Share by Type (2012-2017)
Table Middle East Non-Insulin Therapies for Diabetes Sales () by Applications (2012-2017)
Table Middle East Non-Insulin Therapies for Diabetes Market Share by Applications (2012-2017)
Figure Middle East Non-Insulin Therapies for Diabetes Sales Market Share by Application in 2016
Table Middle East Non-Insulin Therapies for Diabetes Sales Volume () by Countries (2012-2017)
Table Middle East Non-Insulin Therapies for Diabetes Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Non-Insulin Therapies for Diabetes Sales Volume Market Share by Countries in 2016
Table Middle East Non-Insulin Therapies for Diabetes Revenue (Million USD) by Countries (2012-2017)
Table Middle East Non-Insulin Therapies for Diabetes Revenue Market Share by Countries (2012-2017)
Figure Middle East Non-Insulin Therapies for Diabetes Revenue Market Share by Countries (2012-2017)
Figure Middle East Non-Insulin Therapies for Diabetes Revenue Market Share by Countries in 2016
Figure Saudi Arabia Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Israel Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure UAE Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Iran Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Africa Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Africa Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Non-Insulin Therapies for Diabetes Sales () by Type (2012-2017)
Table Africa Non-Insulin Therapies for Diabetes Sales Market Share by Type (2012-2017)
Figure Africa Non-Insulin Therapies for Diabetes Sales Market Share by Type (2012-2017)
Figure Africa Non-Insulin Therapies for Diabetes Sales Market Share by Type in 2016
Table Africa Non-Insulin Therapies for Diabetes Sales () by Application (2012-2017)
Table Africa Non-Insulin Therapies for Diabetes Sales Market Share by Application (2012-2017)
Figure Africa Non-Insulin Therapies for Diabetes Sales Market Share by Application (2012-2017)
Table Africa Non-Insulin Therapies for Diabetes Sales Volume () by Countries (2012-2017)
Table Africa Non-Insulin Therapies for Diabetes Sales Market Share by Countries (2012-2017)
Figure Africa Non-Insulin Therapies for Diabetes Sales Market Share by Countries (2012-2017)
Figure Africa Non-Insulin Therapies for Diabetes Sales Market Share by Countries in 2016
Table Africa Non-Insulin Therapies for Diabetes Revenue (Million USD) by Countries (2012-2017)
Table Africa Non-Insulin Therapies for Diabetes Revenue Market Share by Countries (2012-2017)
Figure Africa Non-Insulin Therapies for Diabetes Revenue Market Share by Countries (2012-2017)
Figure Africa Non-Insulin Therapies for Diabetes Revenue Market Share by Countries in 2016
Figure South Africa Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Nigeria Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Egypt Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Algeria Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Table GSK Non-Insulin Therapies for Diabetes Basic Information List
Table GSK Non-Insulin Therapies for Diabetes Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure GSK Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure GSK Non-Insulin Therapies for Diabetes Sales Market Share in EMEA (2012-2017)
Figure GSK Non-Insulin Therapies for Diabetes Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Non-Insulin Therapies for Diabetes Basic Information List
Table Eli Lilly Non-Insulin Therapies for Diabetes Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Eli Lilly Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Eli Lilly Non-Insulin Therapies for Diabetes Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Non-Insulin Therapies for Diabetes Revenue Market Share in EMEA (2012-2017)
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Basic Information List
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Sales Market Share in EMEA (2012-2017)
Figure Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Revenue Market Share in EMEA (2012-2017)
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Basic Information List
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Intarcia Therapeutics Non-Insulin Therapies for Diabetes Sales Market Share in EMEA (2012-2017)
Figure Intarcia Therapeutics Non-Insulin Therapies for Diabetes Revenue Market Share in EMEA (2012-2017)
Table Servier Non-Insulin Therapies for Diabetes Basic Information List
Table Servier Non-Insulin Therapies for Diabetes Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Servier Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Servier Non-Insulin Therapies for Diabetes Sales Market Share in EMEA (2012-2017)
Figure Servier Non-Insulin Therapies for Diabetes Revenue Market Share in EMEA (2012-2017)
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Basic Information List
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Sales Market Share in EMEA (2012-2017)
Figure Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Non-Insulin Therapies for Diabetes Basic Information List
Table Novo Nordisk Non-Insulin Therapies for Diabetes Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Novo Nordisk Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Novo Nordisk Non-Insulin Therapies for Diabetes Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Non-Insulin Therapies for Diabetes Revenue Market Share in EMEA (2012-2017)
Table Emisphere Non-Insulin Therapies for Diabetes Basic Information List
Table Emisphere Non-Insulin Therapies for Diabetes Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Emisphere Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Emisphere Non-Insulin Therapies for Diabetes Sales Market Share in EMEA (2012-2017)
Figure Emisphere Non-Insulin Therapies for Diabetes Revenue Market Share in EMEA (2012-2017)
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Basic Information List
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Uni-Bio Science Group Non-Insulin Therapies for Diabetes Sales Market Share in EMEA (2012-2017)
Figure Uni-Bio Science Group Non-Insulin Therapies for Diabetes Revenue Market Share in EMEA (2012-2017)
Table Takeda Non-Insulin Therapies for Diabetes Basic Information List
Table Takeda Non-Insulin Therapies for Diabetes Sales (), Revenue (Million USD), Price () and Gross Margin (2012-2017)
Figure Takeda Non-Insulin Therapies for Diabetes Sales () and Growth Rate (2012-2017)
Figure Takeda Non-Insulin Therapies for Diabetes Sales Market Share in EMEA (2012-2017)
Figure Takeda Non-Insulin Therapies for Diabetes Revenue Market Share in EMEA (2012-2017)
Table 3SBio Non-Insulin Therapies for Diabetes Basic Information List
Table Merck Non-Insulin Therapies for Diabetes Basic Information List
Table Dong-A Pharmaceutical Non-Insulin Therapies for Diabetes Basic Information List
Table Luye Pharma Group Non-Insulin Therapies for Diabetes Basic Information List
Table Eurofarma Non-Insulin Therapies for Diabetes Basic Information List
Table Geropharm Non-Insulin Therapies for Diabetes Basic Information List
Table Alkem Labs Non-Insulin Therapies for Diabetes Basic Information List
Table SatRx Non-Insulin Therapies for Diabetes Basic Information List
Table Pfizer Non-Insulin Therapies for Diabetes Basic Information List
Table Jiangsu Hengrui Medicine Non-Insulin Therapies for Diabetes Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-Insulin Therapies for Diabetes
Figure Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
Figure Non-Insulin Therapies for Diabetes Industrial Chain Analysis
Table Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2016
Table Major Buyers of Non-Insulin Therapies for Diabetes
Table Distributors/Traders List
Figure EMEA Non-Insulin Therapies for Diabetes Sales () and Growth Rate Forecast (2017-2022)
Figure EMEA Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Non-Insulin Therapies for Diabetes Price () and Trend Forecast (2017-2022)
Table EMEA Non-Insulin Therapies for Diabetes Sales () Forecast by Region (2017-2022)
Figure EMEA Non-Insulin Therapies for Diabetes Sales Market Share Forecast by Region (2017-2022)
Table EMEA Non-Insulin Therapies for Diabetes Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Non-Insulin Therapies for Diabetes Revenue Market Share Forecast by Region (2017-2022)
Table Europe Non-Insulin Therapies for Diabetes Sales () Forecast by Countries (2017-2022)
Figure Europe Non-Insulin Therapies for Diabetes Sales Market Share Forecast by Countries (2017-2022)
Table Europe Non-Insulin Therapies for Diabetes Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Non-Insulin Therapies for Diabetes Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Non-Insulin Therapies for Diabetes Sales () Forecast by Countries (2017-2022)
Figure Middle East Non-Insulin Therapies for Diabetes Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Non-Insulin Therapies for Diabetes Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Non-Insulin Therapies for Diabetes Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Non-Insulin Therapies for Diabetes Sales () Forecast by Countries (2017-2022)
Figure Africa Non-Insulin Therapies for Diabetes Sales Market Share Forecast by Countries (2017-2022)
Table Africa Non-Insulin Therapies for Diabetes Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Non-Insulin Therapies for Diabetes Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Non-Insulin Therapies for Diabetes Sales () Forecast by Type (2017-2022)
Figure EMEA Non-Insulin Therapies for Diabetes Sales Market Share Forecast by Type (2017-2022)
Table EMEA Non-Insulin Therapies for Diabetes Sales () Forecast by Application (2017-2022)
Figure EMEA Non-Insulin Therapies for Diabetes Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources